Anthocyanins clinical trials at UC Davis
1 research study open to eligible people
open to eligible people ages 18-35
This study will investigate the capacity of an anthocyanin-rich blend (ACRB) dietary supplement to improve the alterations in lipid and glucose homeostasis triggered by consumption of a high-fat meal. Given the impact of Western style diets and obesity on the development of type 2 diabetes, cardiovascular disease and other pathologies, this study has major public health implications.
Our lead scientists for Anthocyanins research studies include Patricia Oteiza, PhD.